338 related articles for article (PubMed ID: 15064337)
21. A comparison of reteplase with alteplase for acute myocardial infarction.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
[TBL] [Abstract][Full Text] [Related]
22. Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy.
Semba CP; Bakal CW; Calis KA; Grubbs GE; Hunter DW; Matalon TA; Murphy TP; Stump DC; Thomas S; Warner DL
J Vasc Interv Radiol; 2000 Mar; 11(3):279-87. PubMed ID: 10735420
[No Abstract] [Full Text] [Related]
23. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.
Clase CM; Crowther MA; Ingram AJ; Cinà CS
J Thromb Thrombolysis; 2001 Apr; 11(2):127-36. PubMed ID: 11406727
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
[TBL] [Abstract][Full Text] [Related]
25. Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis.
Ouriel K; Kaul AF; Leonard MC
J Vasc Surg; 2004 Nov; 40(5):971-7. PubMed ID: 15557913
[TBL] [Abstract][Full Text] [Related]
26. Declining-dose study of reteplase treatment for lower extremity arterial occlusions.
Castañeda F; Swischuk JL; Li R; Young K; Smouse B; Brady T
J Vasc Interv Radiol; 2002 Nov; 13(11):1093-8. PubMed ID: 12427807
[TBL] [Abstract][Full Text] [Related]
27. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
[TBL] [Abstract][Full Text] [Related]
28. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
29. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy.
Vedantham S; Vesely TM; Parti N; Darcy M; Hovsepian DM; Picus D
J Vasc Interv Radiol; 2002 Oct; 13(10):1001-8. PubMed ID: 12397121
[TBL] [Abstract][Full Text] [Related]
30. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
31. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
Eyrich H; Walton T; Macon EJ; Howe A
Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
[TBL] [Abstract][Full Text] [Related]
32. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes.
Kim HS; Patra A; Paxton BE; Khan J; Streiff MB
J Vasc Interv Radiol; 2006 Jul; 17(7):1099-104. PubMed ID: 16868161
[TBL] [Abstract][Full Text] [Related]
33. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.
Semba CP; Dake MD
Radiology; 1994 May; 191(2):487-94. PubMed ID: 8153327
[TBL] [Abstract][Full Text] [Related]
34. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials.
Weaver WD
Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443
[TBL] [Abstract][Full Text] [Related]
35. Catheter-directed thrombolysis with percutaneous rheolytic thrombectomy versus thrombolysis alone in upper and lower extremity deep vein thrombosis.
Kim HS; Patra A; Paxton BE; Khan J; Streiff MB
Cardiovasc Intervent Radiol; 2006; 29(6):1003-7. PubMed ID: 16967220
[TBL] [Abstract][Full Text] [Related]
36. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.
Ouriel K; Welch EL; Shortell CK; Geary K; Fiore WM; Cimino C
J Vasc Surg; 1995 Nov; 22(5):593-7. PubMed ID: 7494361
[TBL] [Abstract][Full Text] [Related]
37. Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis.
Hilleman DE; Razavi MK
J Vasc Interv Radiol; 2008 Mar; 19(3):377-83. PubMed ID: 18295697
[TBL] [Abstract][Full Text] [Related]
38. Deep venous thrombosis associated with protein C and/or S deficiency: management with catheter-directed thrombolysis.
Cho YP; Jang HJ; Lee DH; Ahn J; Han MS; Kim JS; Kim YH; Lee SG
Br J Radiol; 2003 Jun; 76(906):380-4. PubMed ID: 12814923
[TBL] [Abstract][Full Text] [Related]
39. Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
Goldhaber SZ; Hirsch DR; MacDougall RC; Polak JF; Creager MA
Am Heart J; 1996 Aug; 132(2 Pt 1):314-8. PubMed ID: 8701892
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter regional urokinase therapy in the management of inferior vena cava thrombosis.
Angle JF; Matsumoto AH; Al Shammari M; Hagspiel KD; Spinosa DJ; Humphries JE
J Vasc Interv Radiol; 1998; 9(6):917-25. PubMed ID: 9840035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
